Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Maxcyte (MXCT) Current Leases (2020 - 2025)

Historic Current Leases for Maxcyte (MXCT) over the last 6 years, with Q3 2025 value amounting to $1.3 million.

  • Maxcyte's Current Leases rose 4487.32% to $1.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.3 million, marking a year-over-year increase of 4487.32%. This contributed to the annual value of $864000.0 for FY2024, which is 1162.79% up from last year.
  • As of Q3 2025, Maxcyte's Current Leases stood at $1.3 million, which was up 4487.32% from $1.3 million recorded in Q2 2025.
  • Maxcyte's 5-year Current Leases high stood at $1.3 million for Q3 2025, and its period low was $152200.0 during Q3 2022.
  • Its 5-year average for Current Leases is $709033.3, with a median of $657600.0 in 2021.
  • Per our database at Business Quant, Maxcyte's Current Leases crashed by 7340.56% in 2022 and then surged by 39299.36% in 2023.
  • Maxcyte's Current Leases (Quarter) stood at $527200.0 in 2021, then crashed by 70.22% to $157000.0 in 2022, then skyrocketed by 392.99% to $774000.0 in 2023, then grew by 11.63% to $864000.0 in 2024, then surged by 52.08% to $1.3 million in 2025.
  • Its last three reported values are $1.3 million in Q3 2025, $1.3 million for Q2 2025, and $1.3 million during Q1 2025.